Precision Molecular Pathology of Aggressive B-Cell Lymphomas

$158.99

Taxes may apply at checkout.

Precision Molecular Pathology of Aggressive B-Cell Lymphomas

Clinical and internal medicine Pathology

Dinosaur mascot

Collection: Molecular Pathology Library

Language: English

Published by: Springer

Published on: 14th February 2024

Format: LCP-protected ePub

ISBN: 9783031468421


Written by experts in the field

Precision Molecular Pathology of Aggressive B-Cell Lymphomas contains the most recent revisions from the 5th Edition WHO and 2022 International Consensus Classification diagnostic categories and serves as an important resource for trainees, pathologists, haematologist/oncologists, other clinicians involved in lymphoma care and lymphoma researchers. It provides a comprehensive yet concise synthesis of emerging molecular advances that inform patient care and improve understanding of disease mechanisms. In addition, it provides the necessary background to how molecular techniques are performed to enable the reader to better interpret and critically evaluate relevant and emerging data.

Part 1: Background and Classification

As part of the Molecular Pathology Library series, this book focuses specifically on aggressive B-cell lymphomas given the increasing relevance of molecular data for diagnosis and treatment of these disorders. This evidence-based text contains 25 chapters and is divided into 5 parts. Part 1 provides a brief history and background of aggressive B-cell lymphomas. Landmark events in their classification and treatment are given in order to place the substantial advances in the field in context.

Part 2: Molecular Pathology Methods

Part 2 reviews molecular pathology methods, including the increasing use of next generation sequencing techniques in clinical practice.

Parts 3 and 4: Subtypes of Aggressive B-Cell Lymphoma

Parts 3 and 4 focus on individual subtypes of aggressive B-cell lymphoma, including a summary of the diagnostic criteria and key pathologic and clinical features for each entity.

Part 5: Emerging Technologies

Finally, Part 5 focuses on emerging molecular technologies that may significantly impact clinical practice.

Show moreShow less